O'Shaughnessy Asset Management, LLC Karuna Therapeutics, Inc. Transaction History

O'Shaughnessy Asset Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	SELL	$176.32 - $240.22 $5,465 - $7,446	-31 Reduced 2.27%	1,336 $289,000
Q1 2023 May 12, 2023	SELL	$161.33 - $204.36 $16,455 - $20,844	-102 Reduced 6.94%	1,367 $248,000
Q4 2022 Feb 10, 2023	SELL	$191.53 - $236.82 $1,532 - $1,894	-8 Reduced 0.54%	1,469 $288,000
Q3 2022 Nov 14, 2022	BUY	$123.79 - $277.42 $182,837 - $409,749	1,477 New	1,477 $332,000
Q4 2021 Feb 11, 2022	SELL	$110.64 - $159.4 $60,409 - $87,032	-546 Closed	0 $0
Q2 2021 Aug 09, 2021	BUY	$107.45 - $135.95 $58,667 - $74,228	546 New	546 $62,000

332K

Ticker KRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,965,000
Description
Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...

Get notified when there are updates to the investment portfolio of O'Shaughnessy Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on O'Shaughnessy Asset Management, LLC with notifications on news.